Creative Biolabs-Immuno-oncology

Anti-DLX1 (clone 3C7J) SynExpress pB-mKa-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR2148)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLX1 (clone 3C7J). We employs the Lentivirus (pBAD-mKate-c-Jun-KpnI) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DLX1
Clone
3C7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
pBAD
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
Lentivirus
Transformation Accuracy
0.98
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.